Page last updated: 2024-08-18

pyridostigmine bromide and Extrasystole, Ventricular

pyridostigmine bromide has been researched along with Extrasystole, Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castro, RRT; da Nóbrega, ACL; Ferlin, EL; Moraes, RS; Porphirio, G; Ribeiro, JP; Xavier, SS1
Bigelow, AM; Clark, JM; Khalifa, MM1

Trials

1 trial(s) available for pyridostigmine bromide and Extrasystole, Ventricular

ArticleYear
Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease.
    Cardiovascular therapeutics, 2017, Volume: 35, Issue:5

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Asymptomatic Diseases; Brazil; Chagas Cardiomyopathy; Cholinesterase Inhibitors; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Pyridostigmine Bromide; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Premature Complexes

2017

Other Studies

1 other study(ies) available for pyridostigmine bromide and Extrasystole, Ventricular

ArticleYear
Imipramine for incessant ventricular arrhythmias in 2 unrelated patients with Andersen-Tawil syndrome.
    Heart rhythm, 2015, Volume: 12, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Adult; Andersen Syndrome; Cholinesterase Inhibitors; Defibrillators, Implantable; Disease Management; Drug Resistance; Electrocardiography; Female; Humans; Imipramine; Mutation; Potassium Channels, Inwardly Rectifying; Pyridostigmine Bromide; Treatment Outcome; Ventricular Premature Complexes

2015